Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics sets November 12, 2026 annual meeting; stockholder deadline is September 24

Neutral Impact 2 of 5 shareholder Written later

Elicio Therapeutics has set November 12, 2026 as the date of its 2026 annual meeting of stockholders. Because the meeting date moves by more than 30 days from the anniversary of its last annual meeting, the company set September 24, 2026 as the deadline for stockholder proposals and director nominations.

Key points

  • Annual meeting date set for November 12, 2026; exact time, location and voting matters to be detailed in the proxy statement
  • Deadline for Rule 14a-8 stockholder proposals and bylaw notices of director nominations: September 24, 2026
  • Universal proxy notices under Rule 14a-19 also due by September 24, 2026

The filing

CompanyElicio Therapeutics, Inc. (ELTX)
Form8-K, current report
Filed with the SECSep 14, 2026, 4:03 PM ET
Accession number0001601485-26-000058

Items reported: 5.08 Shareholder Director Nominations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.